Key statistics
On Tuesday, ATAI Life Sciences NV (ATAIN:MEX) closed at 35.00, 0.00% below its 52-week high of 35.00, set on May 20, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 35.00 |
---|---|
High | 35.00 |
Low | 35.00 |
Bid | -- |
Offer | -- |
Previous close | 35.00 |
Average volume | -- |
---|---|
Shares outstanding | 200.75m |
Free float | 151.04m |
P/E (TTM) | -- |
Market cap | 441.66m USD |
EPS (TTM) | -0.9129 USD |
Data delayed at least 20 minutes, as of May 20 2025 12:30 BST.
More ▼
Announcements
- atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies
- atai Life Sciences to Participate in Upcoming Investor Conferences
- atai Life Sciences Announces Positive Topline Data from Part 2 of Beckley Psytech’s Phase 2a Study of BPL-003 in Combination with SSRIs for Treatment-Resistant Depression
- atai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate Updates
- atai Life Sciences Announces First Patient Dosed in Phase 2 Study of EMP-01 for the Treatment of Social Anxiety Disorder
- atai Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights
- atai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of VLS-01 for Treatment-Resistant Depression
- atai Life Sciences Announces Completion of Enrollment in Phase 2b Clinical Trial Evaluating BPL-003 for Treatment-Resistant Depression
- atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference
- atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares
More ▼